【Hocance Biotech】Announcement of the Company's Q1 2026 Consolidated Financial Report Submitted to the Board of Directors
Hocance Biotech submitted its Q1 2026 consolidated financial report to the board. For the period from January 1 to March 31, 2026, operating revenue was NT$190,868 thousand, net profit attributable to parent company owners was NT$52,793 thousand, and basic EPS was NT$0.59.
📋 Article Processing Timeline
- 📰 Published: April 28, 2026 at 09:00
- 🔍 Collected: April 29, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: April 29, 2026 at 08:27 (27 min after Collected)
1. Date of submission to the Board of Directors or resolution by the Board of Directors: 2026/04/28
2. Date of approval by the Audit Committee: 2026/04/28
3. Reporting period of financial statements or annual self-declared financial information: 2026/01/01~2026/03/31
4. Cumulative operating revenue from January 1 to the end of this period (in thousands of NTD): 190,868
5. Cumulative operating gross profit (gross loss) from January 1 to the end of this period (in thousands of NTD): 134,561
6. Cumulative operating profit (loss) from January 1 to the end of this period (in thousands of NTD): 58,409
7. Cumulative pre-tax net profit (net loss) from January 1 to the end of this period (in thousands of NTD): 68,648
8. Cumulative net profit (net loss) for this period from January 1 to the end of this period (in thousands of NTD): 52,793
9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands of NTD): 52,793
10. Cumulative basic earnings per share (loss) from January 1 to the end of this period (in NTD): 0.59
11. Total assets at the end of the period (in thousands of NTD): 1,990,823
12. Total liabilities at the end of the period (in thousands of NTD): 364,273
13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 1,626,550
14. Other matters that should be specified: None
2. Date of approval by the Audit Committee: 2026/04/28
3. Reporting period of financial statements or annual self-declared financial information: 2026/01/01~2026/03/31
4. Cumulative operating revenue from January 1 to the end of this period (in thousands of NTD): 190,868
5. Cumulative operating gross profit (gross loss) from January 1 to the end of this period (in thousands of NTD): 134,561
6. Cumulative operating profit (loss) from January 1 to the end of this period (in thousands of NTD): 58,409
7. Cumulative pre-tax net profit (net loss) from January 1 to the end of this period (in thousands of NTD): 68,648
8. Cumulative net profit (net loss) for this period from January 1 to the end of this period (in thousands of NTD): 52,793
9. Cumulative net profit (loss) attributable to owners of the parent company from January 1 to the end of this period (in thousands of NTD): 52,793
10. Cumulative basic earnings per share (loss) from January 1 to the end of this period (in NTD): 0.59
11. Total assets at the end of the period (in thousands of NTD): 1,990,823
12. Total liabilities at the end of the period (in thousands of NTD): 364,273
13. Equity attributable to owners of the parent company at the end of the period (in thousands of NTD): 1,626,550
14. Other matters that should be specified: None